GSEA showed that the WASF2-related gene signatures were also enriched in the malignant features of HCC cells; therefore, we conducted in vitro migration and invasion assays to identify the role of WASF2 in the progression of HCC. The gene discussed is WASF2; the disease is hepatocellular carcinoma.